Case-control study of the parkin gene in early-onset Parkinson disease

Archives of Neurology

Volumn 63, Issue 4, 2006, Pages 548-552

  Clark, Lorraine N ^a,b,c   Afridi, Shehla ^a   Karlins, Eric ^d   Wang, Yuanjia ^b   Mejia Santana, Helen ^d   Harris, Juliette ^b   Louis, Elan D ^a,b,d   Cote, Lucien J ^b,d   Andrews, Howard ^c,d   Fahn, Stanley ^b   Waters, Cheryl ^b   Ford, Blair ^b   Frucht, Steven ^b   Ottman, Ruth ^c,d,e   Marder, Karen ^a,b,c,d  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NONE   (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LEUCINE; LEUCYLLEUCINE; PARKIN; PROLINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; EARLY ONSET PARKINSON DISEASE; EXON; FAMILY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC EPIDEMIOLOGY; GENETIC IDENTIFICATION; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOSITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; POINT MUTATION; UBIQUITIN-PROTEIN LIGASES;

EID: 33645728053     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.4.548     Document Type: Article

References (41)

1. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997;276:2045-2047.
2. Singleton AB, Farrer M, Johnson J, et al. Alpha-synuclein locus triplication causes Parkinson's disease. Science. 2003;302:841.
3. Hedrich K, Eskelson C, Wilmot B, et al. Distribution, type, and origin of Parkin mutations: review and case studies. Mov Disord. 2004;19:1146-1157.
4. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299:256-259.
5. Abou-Sleiman P, Healy D, Quinn N, et al. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol. 2003;54:238-286.
6. Hague S, Rogaeva E, Hernandez D, et al. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol. 2003;54:271-274.
7. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science. 2004;304:1158-1160.
8. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol. 2004;56:424-427.
9. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism. Ann Neurol. 2004;56:329-335.
10. Rohe CF, Montagna P, Breedveld G, et al. Homozygous PINK1 C-terminus mutation causing early-onset parkinsonism. Ann Neurol. 2004;56:427-431.
11. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol. 2004;56:336-341.
12. Dekker MC, Bonifati V, Van Duijn CM. Parkinson's disease: piecing together a genetic jigsaw. Brain. 2003;126(pt 8):1722-1733.
13. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene: French Parkinson's Disease Genetics Study Group. N Engl J Med. 2000;342:1560-1567.
14. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain. 2003;126:1271-1278.
15. Kann M, Jacobs H, Mohrmann K, et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol. 2002;51:621-625.
16. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol. 2001;49:367-376.
17. Hilker R, Klein C, Hedrich K, et al. The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett. 2002;323:50-54.
18. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 2003;54:176-185.
19. Munhoz RP, Sa DS, Rogaeva E, et al. Clinical findings in a large family with a parkin ex3delta40 mutation. Arch Neurol. 2004;61:701-704.
20. Lincoln SJ, Maraganore DM, Lesnick TG, et al. Parkin variants in North American Parkinson's disease: cases and controls. Mov Disord. 2003;18:1306-1311.
21. Clark LN, Afridi S, Mejia-Santana H, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov Disord. 2004;19:796-800.
22. Clark LN, Nicolai A, Afridi S, et al. Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord. 2005;20:100-103.
23. Marder K, Levy G, Louis ED, et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol. 2003;54:507-513.
24. Hedrich K, Marder K, Harris J, et al. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology. 2002;58:1239-1246.
25. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259-268.
26. Fahn S, Marsden CD, Calne D. Recent Developments in Parkinson's Disease. Florham Park, NJ: Macmillan Healthcare Information; 1987.
27. Stern Y, Sano M, Paulson JRM. Modified Mini-Mental State Examination: validity and reliability. Neurology. 1987;37(suppl 1):179.
28. Marder K, Levy G, Louis ED, et al. Accuracy of family history data on Parkinson's disease. Neurology. 2003;61:18-23.
29. West A, Periquet M, Lincoln S, et al. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet. 2002;114:584-591.
30. Pigullo S, De Luca A, Barone P, et al. Mutational analysis of parkin gene by denaturing high-performance liquid chromatography (DHPLC) in essential tremor. Parkinsonism Relat Disord. 2004;10:357-362.
31. Lucking CB, Brice A. Semiquantitative PCR for the detection of exon rearrangements in the Parkin gene. Methods Mol Biol. 2003;217:13-26.
32. Poorkaj P, Nutt JG, James D, et al. Parkin mutation analysis in clinic patients with early-onset Parkinson's disease. Am J Med Genet A. 2005;139A:56.
33. Oliveira SA, Scott WK, Martin ER, et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol. 2003;53:624-629.
34. Abbas N, Lucking CB, Ricard S, et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe: French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet. 1999;8:567-574.
35. Foroud T, Uniacke SK, Liu L, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology. 2003;60:796-801.
36. Hedrich K, Djarmati A, Schafer N, et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology. 2004;62:389-394.
37. Bertoli-Avella AM, Giroud-Benitez JL, Akyol A, et al. Novel parkin mutations detected in patients with early-onset Parkinson's disease. Mov Disord. 2005;20:424-431.
38. Hedrich K, Pramstaller PP, Stubke K, et al. Premutations in the FMR1 gene as a modifying factor in Parkin-associated Parkinson's disease? Mov Disord. 2005;20:1060-1062.
39. Khan NL, Horta W, Eunson L, et al. Parkin disease in a Brazilian kindred: manifesting heterozygotes and clinical follow-up over 10 years. Mov Disord. 2005;20:479-484.
40. Wu RM, Bounds R, Lincoln S, et al. Parkin mutations and early-onset parkinsonism in a Taiwanese cohort. Arch Neurol. 2005;62:82-87.
41. Cookson MR, Lockhart PJ, McLendon C, et al. RING finger 1 mutations in Parkin produce altered localization of the protein. Hum Mol Genet. 2003;12:2957-2965.